{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:36:51Z","timestamp":1791005811286,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":2498,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.7861\/clinmedicine.17-3-258","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T03:35:31Z","timestamp":1496288131000},"page":"258-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Adrenal insufficiency \u2013 recognition and management"],"prefix":"10.1016","volume":"17","author":[{"given":"Agnieszka","family":"Pazderska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon HS","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmedicine.17-3-258_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral \u00adcorticosteroids in the United Kingdom","volume":"93","author":"van Staa","year":"2000","journal-title":"QJM"},{"key":"10.7861\/clinmedicine.17-3-258_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between \u00adpremature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.17-3-258_bib3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cen.13125","article-title":"Adrenal insufficiency in patients on long-term opioid analgesia","volume":"85","author":"Gibb","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2265.2002.t01-1-01552.x","article-title":"High prevalence and increasing incidence of Addison\u2019s disease in western Norway","volume":"56","author":"L\u00f8v\u00e5s","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0140-6736(92)91829-W","article-title":"21-Hydroxylase, a major autoantigen in idiopathic Addison\u2019s disease","volume":"339","author":"Winqvist","year":"1992","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.17-3-258_bib6","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.17-3-258_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11102-006-0408-5","article-title":"Isolated corticotrophin deficiency","volume":"9","author":"Andrioli","year":"2006","journal-title":"Pituitary"},{"key":"10.7861\/clinmedicine.17-3-258_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/joim.12162","article-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","volume":"275","author":"Husebye","year":"2014","journal-title":"J Intern Med"},{"key":"10.7861\/clinmedicine.17-3-258_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9343(85)90022-1","article-title":"Reversible hyperthyrotropinemia, \u00adhyperthyroxinemia, and hyperprolactinemia due to adrenal \u00adinsufficiency","volume":"79","author":"Stryker","year":"1985","journal-title":"Am J Med"},{"key":"10.7861\/clinmedicine.17-3-258_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3109\/02770903.2011.606580","article-title":"Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir","volume":"48","author":"Mahlab-Guri","year":"2011","journal-title":"J Asthma"},{"key":"10.7861\/clinmedicine.17-3-258_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcf.2012.10.007","article-title":"Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis","volume":"12","author":"Gilchrist","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.7861\/clinmedicine.17-3-258_bib12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MAJ.0b013e3181db6b7a","article-title":"Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients","volume":"339","author":"Bleicken","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.7861\/clinmedicine.17-3-258_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2265.1987.tb00780.x","article-title":"Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency","volume":"26","author":"H\u00e4gg","year":"1987","journal-title":"Clin Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cen.12097","article-title":"What is the best diagnostic and therapeutic \u00admanagement strategy for an Addison patient during pregnancy?","volume":"78","author":"Lebbe","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1677\/joe.0.1170467","article-title":"The natural history of adrenal function in autoimmune patients with adrenal autoantibodies","volume":"117","author":"Betterle","year":"1988","journal-title":"J Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2265.2011.04276.x","article-title":"Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies","volume":"76","author":"Baker","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0140-6736(65)91526-6","article-title":"A rapid test of adrenocortical function","volume":"1","author":"Wood","year":"1965","journal-title":"Lancet"},{"key":"10.7861\/clinmedicine.17-3-258_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2265.1987.tb03638.x","article-title":"Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-\u00adadrenocortical function","volume":"26","author":"Lindholm","year":"1987","journal-title":"Clin Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass \u00adspectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.17-3-258_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2265.1997.1340955.x","article-title":"An assessment of optimal hydrocortisone replacement therapy","volume":"46","author":"Howlett","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/BF03347262","article-title":"Comparison of different \u00adregimens of glucocorticoid replacement therapy in patients with hypoadrenalism","volume":"28","author":"Barbetta","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.7861\/clinmedicine.17-3-258_bib22","doi-asserted-by":"crossref","first-page":"90768","DOI":"10.1371\/journal.pone.0090768","article-title":"Cardiovascular risk \u00adfactors in patients with Addison\u2019s disease: a comparative study of South African and Swedish patients","volume":"9","author":"Ross","year":"2014","journal-title":"PLoS One"},{"key":"10.7861\/clinmedicine.17-3-258_bib23","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison\u2019s disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.17-3-258_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MED.0000000000000067","article-title":"Current and emerging therapies for Addison's disease","volume":"21","author":"Napier","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.7861\/clinmedicine.17-3-258_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-12-1094","article-title":"A glucocorticoid education group meeting: an \u00adeffective strategy for improving self-management to prevent adrenal crisis","volume":"169","author":"Repping-Wuts","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/cen.12991","article-title":"Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and \u00addissatisfaction with information","volume":"84","author":"Chapman","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-09-0559","article-title":"Adrenal crisis in treated Addison\u2019s disease: a \u00adpredictable but under-managed event","volume":"162","author":"White","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/EJE-09-0884","article-title":"Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies","volume":"162","author":"Hahner","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.17-3-258_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jc.2011-1926","article-title":"Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation","volume":"97","author":"Johannsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.17-3-258_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/EJE-14-1114","article-title":"Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency","volume":"172","author":"Quinkler","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.7861\/clinmedicine.17-3-258_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12020-015-0681-z","article-title":"Improvement of anthropometric and metabolic parameters, and quality of life \u00adfollowing treatment with dual-release hydrocortisone in patients with Addison\u2019s disease","volume":"51","author":"Giordano","year":"2016","journal-title":"Endocrine"},{"key":"10.7861\/clinmedicine.17-3-258_bib33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2014-3809","article-title":"A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia","volume":"100","author":"Mallappa","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.17-3-258_bib34","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/jc.2013-4253","article-title":"Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison\u2019s disease: a randomized clinical trial","volume":"99","author":"Oksnes","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmedicine.17-3-258_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/cen.12670","article-title":"Circadian hormone profiles and insulin sensitivity in patients with Addison\u2019s disease: a comparison of continuous subcutaneous hydrocortisone \u00adinfusion with conventional glucocorticoid replacement therapy","volume":"83","author":"Bj\u00f6rnsdottir","year":"2015","journal-title":"Clin Endocrinol"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824019328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824019328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmedicine.17-3-258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:35:33Z","timestamp":1761460533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824019328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1470211824019328"],"URL":"https:\/\/doi.org\/10.7861\/clinmedicine.17-3-258","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenal insufficiency \u2013 recognition and management","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmedicine.17-3-258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2017. All rights reserved.","name":"copyright","label":"Copyright"}]}}